Suppr超能文献

溴隐亭对神经源性高血压犬的降压作用。

Antihypertensive action of bromocriptine in neurogenic hypertensive dogs.

作者信息

Montastruc J L, Montastruc P

出版信息

Arch Int Pharmacodyn Ther. 1981 Aug;252(2):210-8.

PMID:7305559
Abstract

The effects of bromocriptine, a dopamine agonist, were studied on blood pressure and heart rate in neurogenic hypertensive (sino-aortic denervated) anaesthetized dogs. Bromocriptine induced a very marked decrease in blood pressure but failed to modify the values of heart rate under our experimental conditions. This anti-hypertensive action of bromocriptine was abolished by pretreatment with dopamine antagonists: haloperidol, sulpiride or metoclopramide. Bilateral nephrectomy or ligature of both renal and mesenteric arteries (i.e. exclusion of the two major beds with postsynaptic dopaminergic receptors) failed to suppress the decrease in blood pressure elicited by bromocriptine in neurogenic hypertensive dogs. These results suggest that the antihypertensive action of bromocriptine in neurogenic hypertensive dogs was mainly due to an action on presynaptic and/or ganglionic peripheral dopaminergic receptors located on sympathetic nerve endings. The potential future importance of dopaminergic agonists as antihypertensive drugs is discussed.

摘要

研究了多巴胺激动剂溴隐亭对神经源性高血压(去窦主动脉神经)麻醉犬血压和心率的影响。在我们的实验条件下,溴隐亭使血压显著下降,但未能改变心率值。多巴胺拮抗剂氟哌啶醇、舒必利或甲氧氯普胺预处理可消除溴隐亭的这种抗高血压作用。双侧肾切除或结扎肾动脉和肠系膜动脉(即排除具有突触后多巴胺能受体的两个主要部位)未能抑制溴隐亭引起的神经源性高血压犬血压下降。这些结果表明,溴隐亭对神经源性高血压犬的抗高血压作用主要是由于其作用于位于交感神经末梢的突触前和/或神经节外周多巴胺能受体。讨论了多巴胺能激动剂作为抗高血压药物未来潜在的重要性。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验